{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:39:43Z","timestamp":1790797183684,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.trim.2008.05.009","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T08:51:44Z","timestamp":1213865504000},"page":"192-196","source":"Crossref","is-referenced-by-count":44,"title":["The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice"],"prefix":"10.1016","volume":"19","author":[{"given":"Jian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Figurski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert J.","family":"Burckart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2008.05.009_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.trim.2008.05.009_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2165\/00003495-199651020-00007","article-title":"Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation","volume":"51","author":"Fulton","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.trim.2008.05.009_bib3","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trim.2008.05.009_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trim.2008.05.009_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/dmd.105.006122","article-title":"Role of Mrp2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect of cyclosporine","volume":"34","author":"Westley","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.trim.2008.05.009_bib6","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trim.2008.05.009_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0005-2736(99)00169-8","article-title":"Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance","volume":"1461","author":"Konig","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trim.2008.05.009_bib8","doi-asserted-by":"crossref","first-page":"F139","DOI":"10.1152\/ajprenal.00240.2003","article-title":"Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney","volume":"287","author":"Lim","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trim.2008.05.009_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1043-6618(03)00187-7","article-title":"Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice","volume":"48","author":"Elamiri","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.trim.2008.05.009_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0009-9236(03)00168-1","article-title":"Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus","volume":"74","author":"Hesselink","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trim.2008.05.009_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00007691-200102000-00007","article-title":"Mycophenolic acid plasma concentrations: influence of comedication","volume":"23","author":"Pou","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trim.2008.05.009_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.103.063073","article-title":"Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats","volume":"309","author":"Kobayashi","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trim.2008.05.009_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00007691-200104000-00005","article-title":"Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid","volume":"23","author":"van Gelder","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trim.2008.05.009_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1053-2498(00)00289-8","article-title":"Co-administration of tacrolimus and mycophenolate mofetil does not increase mycophenolic acid (MPA) exposure, but co-administration of cyclosporine inhibits the enterohepatic recirculation of MPA, thereby decreasing its exposure","volume":"20","author":"Van Gelder","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trim.2008.05.009_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hep.510300220","article-title":"Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2","volume":"30","author":"Kamisako","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.trim.2008.05.009_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0009-9236(98)90058-3","article-title":"The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation","volume":"64","author":"Hale","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trim.2008.05.009_bib17","first-page":"511","article-title":"HPLC-MS\/MS method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites","volume":"29","author":"Figurski","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trim.2008.05.009_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/01.tp.0000235533.29300.e7","article-title":"Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients","volume":"82","author":"Naesens","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2008.05.009_bib19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/01.tp.0000231874.53240.ba","article-title":"Circadian pharmacokinetics of mycophenolic acid and implication of genetic polymorphisms for early clinical events in renal transplant recipients","volume":"82","author":"Satoh","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2008.05.009_bib20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.clpt.6100073","article-title":"The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers","volume":"81","author":"Levesque","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trim.2008.05.009_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clpt.2006.08.002","article-title":"Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients","volume":"80","author":"Naesens","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trim.2008.05.009_bib22","first-page":"511","article-title":"HPLC-MS\/MS method for simultaneous quantification of total or free fraction of mycophenolic Acid and its glucuronide metabolites","volume":"29","author":"Figurski","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trim.2008.05.009_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/dmd.107.017210","article-title":"Glucuronidation of mycophenolic acid by Wistar and Mrp2-deficient TR-rat liver microsomes","volume":"36","author":"Westley","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.trim.2008.05.009_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1067\/mcp.2001.113183","article-title":"The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups","volume":"69","author":"Mancinelli","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trim.2008.05.009_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00007890-199901270-00026","article-title":"Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity","volume":"67","author":"Kaplan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2008.05.009_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.1552-4604.1996.tb04207.x","article-title":"Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration","volume":"36","author":"Bullingham","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.trim.2008.05.009_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1034\/j.1399-0012.2000.140301.x","article-title":"Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics","volume":"14","author":"Pescovitz","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trim.2008.05.009_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/clinchem\/41.7.1011","article-title":"Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics","volume":"41","author":"Nowak","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.trim.2008.05.009_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1023\/B:PHAM.0000026420.79421.8f","article-title":"The complexities of hepatic drug transport: current knowledge and emerging concepts","volume":"21","author":"Chandra","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.trim.2008.05.009_bib30","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0026-895X(24)13278-6","article-title":"Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats","volume":"53","author":"Hirohashi","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.trim.2008.05.009_bib31","doi-asserted-by":"crossref","first-page":"G438","DOI":"10.1152\/ajpgi.2000.278.3.G438","article-title":"Characterization of inducible nature of MRP3 in rat liver","volume":"278","author":"Ogawa","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trim.2008.05.009_bib32","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/hep.510290404","article-title":"Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane","volume":"29","author":"Konig","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.trim.2008.05.009_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/dmd.105.005793","article-title":"Characterization of transport protein expression in multidrug resistance-associated protein (Mrp) 2-deficient rats","volume":"34","author":"Johnson","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.trim.2008.05.009_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.106.101774","article-title":"Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice","volume":"318","author":"Vlaming","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trim.2008.05.009_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/jpet.105.098665","article-title":"Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2)","volume":"317","author":"Chu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trim.2008.05.009_bib36","first-page":"925","article-title":"Pharmacokinetics of mycophenolate mofetil (RS61443): a short review","volume":"28","author":"Bullingham","year":"1996","journal-title":"Transplant Proc"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327408000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327408000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:53:35Z","timestamp":1738263215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327408000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":36,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0966327408000464"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2008.05.009","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}